MCID: NRN016
MIFTS: 40

Neuronal Migration Disorders

Categories: Neuronal diseases

Aliases & Classifications for Neuronal Migration Disorders

MalaCards integrated aliases for Neuronal Migration Disorders:

Name: Neuronal Migration Disorders 55
Abnormality of Neuronal Migration 30 6
Malformations of Cortical Development, Group Ii 74
Neuronal Migration Disorder 38

Classifications:



External Ids:

KEGG 38 H01835
UMLS 74 C1837249

Summaries for Neuronal Migration Disorders

NINDS : 55 Neuronal migration disorders (NMDs) are a group of birth defects caused by the abnormal migration of neurons in the developing brain and nervous system. In the developing brain, neurons must migrate from the areas where they are born to the areas where they will settle into their proper neural circuits. Neuronal migration, which occurs as early as the second month of gestation, is controlled by a complex assortment of chemical guides and signals. When these signals are absent or incorrect, neurons do not end up where they belong. This can result in structurally abnormal or missing areas of the brain in the cerebral hemispheres, cerebellum, brainstem, or hippocampus. The structural abnormalities found in NMDs include schizencephaly, porencephaly, lissencephaly, agyria, macrogyria, polymicrogyria, pachygyria, microgyria, micropolygyria, neuronal heterotopias (including band heterotopia), agenesis of the corpus callosum, and agenesis of the cranial nerves. Symptoms vary according to the abnormality, but often feature poor muscle tone and motor function, seizures, developmental delays, impaired cognitive development, failure to grow and thrive, difficulties with feeding, swelling in the extremities, and a smaller than normal head. Most infants with an NMD appear normal, but some disorders have characteristic facial or skull features that can be recognized by a neurologist. Several genetic abnormalities in children with NMDs have been identified. Defects in genes that are involved in neuronal migration have been associated with NMDs, but the role they play in the development of these disorders is not yet well-understood. More than 25 syndromes resulting from abnormal neuronal migration have been described. Among them are syndromes with several different patterns of inheritance; genetic counseling thus differs greatly between syndromes.

MalaCards based summary : Neuronal Migration Disorders, also known as abnormality of neuronal migration, is related to lissencephaly 1 and pachygyria. An important gene associated with Neuronal Migration Disorders is TUBA1A (Tubulin Alpha 1a), and among its related pathways/superpathways are Neuroscience and Cytoskeletal Signaling. The drugs Dopamine and Levodopa have been mentioned in the context of this disorder. Affiliated tissues include brain, cerebellum and skin, and related phenotypes are behavior/neurological and growth/size/body region

Wikipedia : 77 Neuronal migration disorder (NMD) refers to a heterogenous group of disorders that, it is supposed,... more...

Related Diseases for Neuronal Migration Disorders

Diseases related to Neuronal Migration Disorders via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 63)
# Related Disease Score Top Affiliating Genes
1 lissencephaly 1 31.7 DCX PAFAH1B1 RELN
2 pachygyria 30.2 PAFAH1B1 TUBA1A
3 epilepsy 29.9 ARX DCX RELN SCN1A
4 periventricular nodular heterotopia 29.6 DCX PAFAH1B1 RELN TUBA1A
5 band heterotopia 29.4 DCX PAFAH1B1 RELN TUBA1A
6 lissencephaly 29.0 ARX DCX PAFAH1B1 RELN TUBA1A
7 pachygyria with mental retardation, seizures, and arachnoid cysts 11.1
8 flna-related periventricular nodular heterotopia 11.1
9 colpocephaly 11.1
10 chromosome 17p13.3, centromeric, duplication syndrome 10.3 DCX PAFAH1B1
11 lissencephaly 2 10.2 ARX RELN
12 ependymoblastoma 10.2 NES VIM
13 astroblastoma 10.2 NES VIM
14 medulloepithelioma 10.2 NES VIM
15 odontoma 10.2 NES VIM
16 osteochondroma 10.1 NES VIM
17 cerebellar hypoplasia 10.1 DCX PAFAH1B1 RELN
18 optic nerve glioma 10.1 NES VIM
19 neurilemmoma 10.1 NES VIM
20 miller-dieker lissencephaly syndrome 10.1 PAFAH1B1 TUBA1A
21 ependymoma 10.0 NES VIM
22 hydranencephaly 10.0 ARX TUBA1A
23 focal epilepsy 10.0
24 lissencephaly, x-linked, 1 10.0 ARX DCX PAFAH1B1
25 infancy electroclinical syndrome 10.0 ARX SCN1A
26 neonatal period electroclinical syndrome 10.0 ARX SCN1A
27 zellweger syndrome 9.9
28 muscular dystrophy 9.9
29 lennox-gastaut syndrome 9.9 DCX SCN1A
30 lissencephaly with cerebellar hypoplasia 9.8 ARX DCX PAFAH1B1 RELN
31 west syndrome 9.8 ARX PAFAH1B1 SCN1A
32 dermatofibrosarcoma protuberans 9.8 NES VIM
33 schizophrenia 9.8
34 major depressive disorder 9.8
35 bipolar disorder 9.8
36 depression 9.8
37 external auditory canal, bilateral atresia of, with congenital vertical talus 9.8
38 microcephalic osteodysplastic primordial dwarfism, type i 9.8
39 muscular dystrophy-dystroglycanopathy , type a, 1 9.8
40 isolated growth hormone deficiency, type ia 9.8
41 knobloch syndrome 1 9.8
42 muscular dystrophy, congenital, lmna-related 9.8
43 corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia 9.8
44 cerebral palsy 9.8
45 holoprosencephaly 9.8
46 temporal lobe epilepsy 9.8
47 walker-warburg syndrome 9.8
48 pseudobulbar palsy 9.8
49 turner syndrome 9.8
50 dyslexia 9.8

Graphical network of the top 20 diseases related to Neuronal Migration Disorders:



Diseases related to Neuronal Migration Disorders

Symptoms & Phenotypes for Neuronal Migration Disorders

MGI Mouse Phenotypes related to Neuronal Migration Disorders:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.86 ARX DCX DYNC1H1 PAFAH1B1 RELN SCN1A
2 growth/size/body region MP:0005378 9.76 ARX DCX DYNC1H1 PAFAH1B1 RELN SCN1A
3 nervous system MP:0003631 9.61 ARX DCX DYNC1H1 PAFAH1B1 RELN SCN1A
4 reproductive system MP:0005389 9.23 ARX DCX DYNC1H1 PAFAH1B1 RELN SCN1A

Drugs & Therapeutics for Neuronal Migration Disorders

Drugs for Neuronal Migration Disorders (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4 62-31-7, 51-61-6 681
2
Levodopa Approved Phase 4 59-92-7 6047
3 Cardiotonic Agents Phase 4
4 Dihydroxyphenylalanine Phase 4
5 Autonomic Agents Phase 4
6 Dopamine Agents Phase 4
7 Peripheral Nervous System Agents Phase 4
8 Sympathomimetics Phase 4
9 Neurotransmitter Agents Phase 4
10 Protective Agents Phase 4
11 Carbidopa, levodopa drug combination Phase 4

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study Unknown status NCT01361373 Phase 4 L- DOPA;placebo
2 Human Epilepsy Genetics--Neuronal Migration Disorders Study Unknown status NCT00041600
3 Quality of Life Assessment Before and After Essure Removal Completed NCT03401437

Search NIH Clinical Center for Neuronal Migration Disorders

Genetic Tests for Neuronal Migration Disorders

Genetic tests related to Neuronal Migration Disorders:

# Genetic test Affiliating Genes
1 Abnormality of Neuronal Migration 30

Anatomical Context for Neuronal Migration Disorders

MalaCards organs/tissues related to Neuronal Migration Disorders:

42
Brain, Cerebellum, Skin, Temporal Lobe, Cortex

Publications for Neuronal Migration Disorders

Articles related to Neuronal Migration Disorders:

(show top 50) (show all 69)
# Title Authors Year
1
Neuronal Migration Disorders. ( 29298944 )
2018
2
Germline and somatic mutations in cortical malformations: Molecular defects in Argentinean patients with neuronal migration disorders. ( 28953922 )
2017
3
Neuronal migration disorders: Focus on the cytoskeleton and epilepsy. ( 26299390 )
2016
4
The relevance of human fetal subplate zone for developmental neuropathology of neuronal migration disorders and cortical dysplasia. ( 25312583 )
2015
5
Genotype-phenotype correlation in neuronal migration disorders and cortical dysplasias. ( 26052266 )
2015
6
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. ( 24548548 )
2014
7
Embryonic disruption of the candidate dyslexia susceptibility gene homolog Kiaa0319-like results in neuronal migration disorders. ( 23831424 )
2013
8
Neuronal migration disorders in microcephalic osteodysplastic primordial dwarfism type I/III. ( 20857301 )
2011
9
Molecular genetics of neuronal migration disorders. ( 21222180 )
2011
10
Neuronal migration disorders. ( 19245832 )
2010
11
New trends in neuronal migration disorders. ( 19264520 )
2010
12
The beta-tubulin gene TUBB2B is involved in a large spectrum of neuronal migration disorders. ( 20101787 )
2010
13
Neuronal migration disorders: clinical, neuroradiologic and genetics aspects. ( 19120042 )
2009
14
Experimental neuronal migration disorders following the administration of ibotenate in hamsters: the role of the subventricular zone in the development of cortical dysplasia. ( 19258286 )
2009
15
Neuronal migration disorders, agenesis of corpus callosum, preauricular skin tag and bilateral morning glory syndrome in a term newborn infant. ( 18388784 )
2008
16
N-cofilin is associated with neuronal migration disorders and cell cycle control in the cerebral cortex. ( 17875668 )
2007
17
Grey matter heterotopia: what EEG-fMRI can tell us about epileptogenicity of neuronal migration disorders. ( 16339793 )
2006
18
Neuronal migration disorders, genetics, and epileptogenesis. ( 15921228 )
2005
19
Neurophysiologic findings of neuronal migration disorders: intrinsic epileptogenicity of focal cortical dysplasia on electroencephalography, electrocorticography, and magnetoencephalography. ( 15921239 )
2005
20
Proceedings of the International Symposium on Neuronal Migration Disorders and Childhood Epilepsies: clinical manifestations, pathomechanisms, and etiopathogenesis. April 16-17, 2004. Tokyo, Japan. ( 16044620 )
2005
21
Are altered excitatory synapses found in neuronal migration disorders? ( 16175215 )
2005
22
Neuronal migration disorders. ( 16417844 )
2005
23
High molecular weight microtubule-associated protein 2 over-expression in neuronal migration disorders caused by N-methyl-D-aspartate receptor activation in hamsters. ( 15008898 )
2004
24
Upregulation of glutamate receptors in rat cerebral cortex with neuronal migration disorders. ( 15201510 )
2004
25
Evidence of neuronal migration disorders in Knobloch syndrome: clinical and molecular analysis of two novel families. ( 12707952 )
2003
26
MRI and EEG findings in surgically treated patients with partial seizures due to neuronal migration disorders, their relations to each other and to surgery outcome. ( 14616299 )
2003
27
Various findings in surgically treated epilepsy patients with dysembryoplastic neuroepithelial tumors in comparison with those of patients with other low-grade brain tumors and other neuronal migration disorders. ( 12423388 )
2002
28
Lactate and other metabolic changes in neuronal migration disorders. ( 11240607 )
2001
29
Pathogenic significance of neuronal migration disorders in temporal lobe epilepsy. ( 11431720 )
2001
30
Neuronal migration disorders. ( 11553932 )
2001
31
Molecular mechanisms of neuronal migration disorders, quo vadis? ( 11899256 )
2001
32
[Development and developmental disorders of the human brain. III. Neuronal migration disorders of the cerebrum]. ( 11268908 )
2001
33
Immunohistochemical expression of doublecortin in the human cerebrum: comparison of normal development and neuronal migration disorders. ( 10773210 )
2000
34
Characterization of neuronal migration disorders in neocortical structures: loss or preservation of inhibitory interneurons? ( 10897147 )
2000
35
Neuronal migration disorders: from genetic diseases to developmental mechanisms. ( 10906798 )
2000
36
Single cause, polymorphic neuronal migration disorders: an animal model. ( 11085292 )
2000
37
Neuronal migration disorders in man. ( 11151046 )
2000
38
Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy. ( 10403210 )
1999
39
The right neuron at the wrong place: biology of heterotopic neurons in cortical neuronal migration disorders, with special reference to associated pathologies. ( 10487203 )
1999
40
Neuronal migration disorders in humans and in mouse models--an overview. ( 10515161 )
1999
41
Electrophysiological responses in vivo of hippocampal CA1 pyramidal neurons in an animal model of neuronal migration disorders. ( 10575261 )
1999
42
Neuronal migration disorders in cerebral palsy. ( 19519643 )
1999
43
Transplacentally induced neuronal migration disorders: an animal model for the study of the epilepsies. ( 9514201 )
1998
44
Characterization of neuronal migration disorders in neocortical structures. II. Intracellular in vitro recordings. ( 9658031 )
1998
45
Neuronal migration disorders: heterotopic neocortical neurons in CA1 provide a bridge between the hippocampus and the neocortex. ( 9707635 )
1998
46
Characterization of neuronal migration disorders in neocortical structures: extracellular in vitro recordings. ( 9786203 )
1998
47
Characterization of neuronal migration disorders in neocortical structures: quantitative receptor autoradiography of ionotropic glutamate, GABA(A) and GABA(B) receptors. ( 9786204 )
1998
48
Congenital muscular dystrophy, white-matter abnormalities, and neuronal migration disorders: the expanding concept. ( 9796753 )
1998
49
Evidence of enhanced kindling and hippocampal neuronal injury in immature rats with neuronal migration disorders. ( 9860059 )
1998
50
Neuronal migration disorders. Part I: Terminology, classification, pathophysiology, EEG and epilepsy. ( 10028855 )
1998

Variations for Neuronal Migration Disorders

ClinVar genetic disease variations for Neuronal Migration Disorders:

6 (show top 50) (show all 210)
# Gene Variation Type Significance SNP ID Assembly Location
1 TTN; TTN-AS1 NM_001267550.2(TTN): c.32462C> T (p.Pro10821Leu) single nucleotide variant Conflicting interpretations of pathogenicity rs146400809 GRCh37 Chromosome 2, 179549988: 179549988
2 TTN; TTN-AS1 NM_001267550.2(TTN): c.32462C> T (p.Pro10821Leu) single nucleotide variant Conflicting interpretations of pathogenicity rs146400809 GRCh38 Chromosome 2, 178685261: 178685261
3 TTN; TTN-AS1 NM_001267550.2(TTN): c.7961G> A (p.Arg2654Lys) single nucleotide variant Likely benign rs147207100 GRCh37 Chromosome 2, 179636093: 179636093
4 TTN; TTN-AS1 NM_001267550.2(TTN): c.7961G> A (p.Arg2654Lys) single nucleotide variant Likely benign rs147207100 GRCh38 Chromosome 2, 178771366: 178771366
5 TUBA1A NM_006009.3(TUBA1A): c.1148C> T (p.Ala383Val) single nucleotide variant Pathogenic/Likely pathogenic rs587784482 GRCh37 Chromosome 12, 49579001: 49579001
6 TUBA1A NM_006009.3(TUBA1A): c.1148C> T (p.Ala383Val) single nucleotide variant Pathogenic/Likely pathogenic rs587784482 GRCh38 Chromosome 12, 49185218: 49185218
7 TTN NM_001267550.2(TTN): c.88972A> G (p.Ile29658Val) single nucleotide variant Conflicting interpretations of pathogenicity rs200193877 GRCh38 Chromosome 2, 178554139: 178554139
8 TTN NM_001267550.2(TTN): c.88972A> G (p.Ile29658Val) single nucleotide variant Conflicting interpretations of pathogenicity rs200193877 GRCh37 Chromosome 2, 179418866: 179418866
9 DMD NM_004013.2(DMD): c.928G> A (p.Asp310Asn) single nucleotide variant Benign/Likely benign rs138399787 GRCh37 Chromosome X, 31525480: 31525480
10 DMD NM_004013.2(DMD): c.928G> A (p.Asp310Asn) single nucleotide variant Benign/Likely benign rs138399787 GRCh38 Chromosome X, 31507363: 31507363
11 MROH2A NM_001287395.1(MROH2A): c.2844_2845insGG (p.Leu950Glyfs) insertion Benign rs863223391 GRCh38 Chromosome 2, 233814656: 233814657
12 THADA NM_001271643.1(THADA): c.2468C> T (p.Ser823Leu) single nucleotide variant Benign rs201555818 GRCh38 Chromosome 2, 43556551: 43556551
13 TTN NM_001267550.2(TTN): c.1051G> A (p.Val351Met) single nucleotide variant Uncertain significance rs772889673 GRCh37 Chromosome 2, 179659843: 179659843
14 TTN NM_001267550.2(TTN): c.1051G> A (p.Val351Met) single nucleotide variant Uncertain significance rs772889673 GRCh38 Chromosome 2, 178795116: 178795116
15 COL3A1 NM_000090.3(COL3A1): c.2110G> A (p.Glu704Lys) single nucleotide variant Uncertain significance rs863223362 GRCh38 Chromosome 2, 188999372: 188999372
16 COL3A1 NM_000090.3(COL3A1): c.2110G> A (p.Glu704Lys) single nucleotide variant Uncertain significance rs863223362 GRCh37 Chromosome 2, 189864098: 189864098
17 MROH2A NM_001287395.1(MROH2A): c.1961G> A (p.Arg654Gln) single nucleotide variant Benign rs863223390 GRCh38 Chromosome 2, 233805011: 233805011
18 MROH2A NM_001287395.1(MROH2A): c.1961G> A (p.Arg654Gln) single nucleotide variant Benign rs863223390 GRCh37 Chromosome 2, 234713657: 234713657
19 MROH2A NM_001287395.1(MROH2A): c.2844_2845insGG (p.Leu950Glyfs) insertion Benign rs863223391 GRCh37 Chromosome 2, 234723302: 234723303
20 THADA NM_001271643.1(THADA): c.2468C> T (p.Ser823Leu) single nucleotide variant Benign rs201555818 GRCh37 Chromosome 2, 43783690: 43783690
21 THADA NM_001271643.1(THADA): c.362G> A (p.Arg121His) single nucleotide variant Benign rs769958179 GRCh38 Chromosome 2, 43586943: 43586943
22 THADA NM_001271643.1(THADA): c.362G> A (p.Arg121His) single nucleotide variant Benign rs769958179 GRCh37 Chromosome 2, 43814082: 43814082
23 NXPE3 NM_001134456.1(NXPE3): c.452_459delTCAAGCTG (p.Leu151Profs) deletion Benign rs863223380 GRCh38 Chromosome 3, 101801593: 101801600
24 NXPE3 NM_001134456.1(NXPE3): c.452_459delTCAAGCTG (p.Leu151Profs) deletion Benign rs863223380 GRCh37 Chromosome 3, 101520437: 101520444
25 NXPE3 NM_001134456.1(NXPE3): c.462delG (p.Ala155Leufs) deletion Benign rs863223381 GRCh38 Chromosome 3, 101801603: 101801603
26 NXPE3 NM_001134456.1(NXPE3): c.462delG (p.Ala155Leufs) deletion Benign rs863223381 GRCh37 Chromosome 3, 101520447: 101520447
27 NXPE3 NM_001134456.1(NXPE3): c.956G> C (p.Gly319Ala) single nucleotide variant Benign rs140150886 GRCh38 Chromosome 3, 101816828: 101816828
28 NXPE3 NM_001134456.1(NXPE3): c.956G> C (p.Gly319Ala) single nucleotide variant Benign rs140150886 GRCh37 Chromosome 3, 101535672: 101535672
29 PARP14 NM_017554.2(PARP14): c.1455T> A (p.Ser485Arg) single nucleotide variant Benign rs863223384 GRCh38 Chromosome 3, 122700009: 122700009
30 PARP14 NM_017554.2(PARP14): c.1455T> A (p.Ser485Arg) single nucleotide variant Benign rs863223384 GRCh37 Chromosome 3, 122418856: 122418856
31 PARP14 NM_017554.2(PARP14): c.2083C> A (p.Pro695Thr) single nucleotide variant Benign rs863223385 GRCh38 Chromosome 3, 122700637: 122700637
32 PARP14 NM_017554.2(PARP14): c.2083C> A (p.Pro695Thr) single nucleotide variant Benign rs863223385 GRCh37 Chromosome 3, 122419484: 122419484
33 TNK2 NM_001010938.1(TNK2): c.1966G> A (p.Val656Met) single nucleotide variant Benign rs375205272 GRCh37 Chromosome 3, 195595392: 195595392
34 TNK2 NM_001010938.1(TNK2): c.1966G> A (p.Val656Met) single nucleotide variant Benign rs375205272 GRCh38 Chromosome 3, 195868521: 195868521
35 TNK2 NM_001010938.1(TNK2): c.955C> T (p.Arg319Cys) single nucleotide variant Benign rs767408627 GRCh37 Chromosome 3, 195609043: 195609043
36 TNK2 NM_001010938.1(TNK2): c.955C> T (p.Arg319Cys) single nucleotide variant Benign rs767408627 GRCh38 Chromosome 3, 195882172: 195882172
37 ATXN7 NM_001177387.1(ATXN7): c.211T> G (p.Ser71Ala) single nucleotide variant Benign rs201561286 GRCh38 Chromosome 3, 63912809: 63912809
38 ATXN7 NM_001177387.1(ATXN7): c.211T> G (p.Ser71Ala) single nucleotide variant Benign rs201561286 GRCh37 Chromosome 3, 63898485: 63898485
39 ATXN7 NM_001177387.1(ATXN7): c.844G> A (p.Val282Met) single nucleotide variant Benign rs863223393 GRCh38 Chromosome 3, 63982277: 63982277
40 ATXN7 NM_001177387.1(ATXN7): c.844G> A (p.Val282Met) single nucleotide variant Benign rs863223393 GRCh37 Chromosome 3, 63967953: 63967953
41 PI4K2B NM_018323.3(PI4K2B): c.10C> A (p.Pro4Thr) single nucleotide variant Benign rs863223383 GRCh38 Chromosome 4, 25234173: 25234173
42 PI4K2B NM_018323.3(PI4K2B): c.10C> A (p.Pro4Thr) single nucleotide variant Benign rs863223383 GRCh37 Chromosome 4, 25235795: 25235795
43 PI4K2B NM_018323.3(PI4K2B): c.861G> T (p.Gln287His) single nucleotide variant Benign rs143048917 GRCh38 Chromosome 4, 25259141: 25259141
44 PI4K2B NM_018323.3(PI4K2B): c.861G> T (p.Gln287His) single nucleotide variant Benign rs143048917 GRCh37 Chromosome 4, 25260763: 25260763
45 TLR6 NM_006068.4(TLR6): c.1729_1730delAT (p.Met577Valfs) deletion Benign rs863223364 GRCh37 Chromosome 4, 38829365: 38829366
46 TLR6 NM_006068.4(TLR6): c.1729_1730delAT (p.Met577Valfs) deletion Benign rs863223364 GRCh38 Chromosome 4, 38827744: 38827745
47 LRRC66 NM_001024611.2(LRRC66): c.1823del (p.Gly608Alafs) deletion Benign rs863223368 GRCh38 Chromosome 4, 51995199: 51995199
48 LRRC66 NM_001024611.2(LRRC66): c.1823del (p.Gly608Alafs) deletion Benign rs863223368 GRCh37 Chromosome 4, 52861365: 52861365
49 ADAM19 NM_033274.4(ADAM19): c.2563C> T (p.Pro855Ser) single nucleotide variant Benign rs863223367 GRCh37 Chromosome 5, 156908939: 156908939
50 ADAM19 NM_033274.4(ADAM19): c.2563C> T (p.Pro855Ser) single nucleotide variant Benign rs863223367 GRCh38 Chromosome 5, 157481931: 157481931

Expression for Neuronal Migration Disorders

Search GEO for disease gene expression data for Neuronal Migration Disorders.

Pathways for Neuronal Migration Disorders

Pathways related to Neuronal Migration Disorders according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 12.08 DCX PAFAH1B1 SCN1A
2 11.75 DCX PAFAH1B1 TUBA1A VIM
3
Show member pathways
11.37 NES TUBA1A VIM
4 10.78 PAFAH1B1 RELN
5 10.7 DYNC1H1 PAFAH1B1
6 10.42 DCX DYNC1H1 PAFAH1B1 RELN

GO Terms for Neuronal Migration Disorders

Cellular components related to Neuronal Migration Disorders according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytoplasmic microtubule GO:0005881 9.32 PAFAH1B1 TUBA1A
2 cell leading edge GO:0031252 9.26 PAFAH1B1 VIM
3 microtubule GO:0005874 9.26 DCX DYNC1H1 PAFAH1B1 TUBA1A
4 microtubule associated complex GO:0005875 9.16 DCX PAFAH1B1
5 cytoskeleton GO:0005856 9.1 DCX DYNC1H1 PAFAH1B1 TUBA1A VIM WDR62

Biological processes related to Neuronal Migration Disorders according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 multicellular organism development GO:0007275 9.92 ARX DCX NES PAFAH1B1 RELN
2 central nervous system development GO:0007417 9.67 DCX NES RELN
3 brain development GO:0007420 9.67 DCX NES PAFAH1B1 RELN
4 ciliary basal body-plasma membrane docking GO:0097711 9.65 DYNC1H1 PAFAH1B1 TUBA1A
5 nervous system development GO:0007399 9.65 ARX DCX NES PAFAH1B1 WDR62
6 regulation of G2/M transition of mitotic cell cycle GO:0010389 9.63 DYNC1H1 PAFAH1B1 TUBA1A
7 cerebral cortex development GO:0021987 9.61 PAFAH1B1 RELN WDR62
8 hippocampus development GO:0021766 9.58 DCX PAFAH1B1 RELN
9 negative regulation of neuron projection development GO:0010977 9.56 PAFAH1B1 VIM
10 mitotic spindle organization GO:0007052 9.55 DYNC1H1 WDR62
11 microtubule-based process GO:0007017 9.54 PAFAH1B1 TUBA1A
12 positive regulation of dendritic spine morphogenesis GO:0061003 9.51 PAFAH1B1 RELN
13 G2/M transition of mitotic cell cycle GO:0000086 9.46 DYNC1H1 NES PAFAH1B1 TUBA1A
14 cerebral cortex tangential migration GO:0021800 9.32 ARX RELN
15 neuron migration GO:0001764 9.26 ARX DCX PAFAH1B1 RELN
16 layer formation in cerebral cortex GO:0021819 8.8 DCX PAFAH1B1 RELN

Molecular functions related to Neuronal Migration Disorders according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 structural molecule activity GO:0005198 9.13 NES TUBA1A VIM
2 dynein intermediate chain binding GO:0045505 8.62 DYNC1H1 PAFAH1B1

Sources for Neuronal Migration Disorders

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....